Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grunberg

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Steroids|December 8, 2000
Alterations in sex steroids and gonadotropins in post-menopausal women subsequent to long-term mifepristone administrationO Heikinheimo, S Ranta, S Grunberg, et al.
Metabolism: Clinical and Experimental|March 1, 1997
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatmentO Heikinheimo, S Ranta, S Grunberg, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|November 16, 2020
Gender differences in barriers to participation in after-school physical activities and related factors in Australian schoolchildren: A cross-sectional studyAndrew Lazarowicz, Rebecca L O'Hara, Jonathan C Broder, et al.
Carcinogenesis|July 1, 1991
Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryR J Parker, I Gill, R Tarone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adductsI Gill, F M Muggia, P M Terheggen, et al.
Brain Pathology (Zurich, Switzerland)|August 5, 2008
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brainMicha M M Wilhelmus, Sentini C S Grunberg, John G J M Bol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Steroids|December 8, 2000
Alterations in sex steroids and gonadotropins in post-menopausal women subsequent to long-term mifepristone administrationO Heikinheimo, S Ranta, S Grunberg, et al.
Metabolism: Clinical and Experimental|March 1, 1997
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatmentO Heikinheimo, S Ranta, S Grunberg, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|November 16, 2020
Gender differences in barriers to participation in after-school physical activities and related factors in Australian schoolchildren: A cross-sectional studyAndrew Lazarowicz, Rebecca L O'Hara, Jonathan C Broder, et al.
Carcinogenesis|July 1, 1991
Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryR J Parker, I Gill, R Tarone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adductsI Gill, F M Muggia, P M Terheggen, et al.
Brain Pathology (Zurich, Switzerland)|August 5, 2008
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brainMicha M M Wilhelmus, Sentini C S Grunberg, John G J M Bol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
Pageof 1